About this episode
Dr Stephanie Manson-Brown is a plastic surgeon and experienced leader in biotech and pharma. As Head of Clinical Development and Vice President of Research and Development at Allergan Aesthetics, an AbbVie company, she and her team run global clinical trial strategy across the aesthetics portfolio of pharmaceuticals and devices. She also co-founded the Science of Aging platform, which brings developments in ageing science to aesthetics.
We explore what R&D means, why she left surgery for industry, her day-to-day role, how new products and devices are developed, acquisitions, market research, why some products never pass the concept stage, clinical trial phases, diversity in trials, digital science and precision medicine, working with the FDA, TGA and other regulators, the Science of Aging meeting, and whether ageing medicine will supersede aesthetics.
What you'll learn
- How new aesthetic products are developed
- What happens in each clinical trial phase
- Why some products never reach market
- How diversity is addressed in trials
- Where ageing science meets aesthetics
Topics
- Research
- Clinical trials
- Allergan
- Regulation
- Longevity
Full transcript
The full transcript for this episode is coming soon.